EQUITY Equity (Tables)
|
9 Months Ended |
Sep. 30, 2025 |
|---|
| Equity [Abstract] |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the nine months ended September 30, 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow Hedge |
|
Cumulative Foreign Currency Translation Adjustments |
|
Total |
|
(in thousands) |
| Balance at December 31, 2024 |
$ |
21,518 |
|
|
$ |
(356,630) |
|
|
$ |
(335,112) |
|
Other comprehensive income (loss) before reclassifications |
(826) |
|
|
187,410 |
|
|
186,584 |
|
| Amount reclassified from AOCI |
(10,363) |
|
|
— |
|
|
(10,363) |
|
| Net other comprehensive income (loss) |
(11,189) |
|
|
187,410 |
|
|
176,221 |
|
| Balance at September 30, 2025 |
$ |
10,329 |
|
|
$ |
(169,220) |
|
|
$ |
(158,891) |
|
|
| Schedule of Weighted Average Number of Shares |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
| Weighted average common shares—basic |
232,043,356 |
|
|
230,374,307 |
|
|
231,706,216 |
|
|
229,923,989 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
| Stock options and restricted stock |
2,708,976 |
|
|
1,941,001 |
|
|
2,891,759 |
|
|
2,226,003 |
|
| Convertible senior notes |
— |
|
|
13,004,660 |
|
|
127,830 |
|
|
3,778,760 |
|
| Weighted average common shares—diluted |
234,752,332 |
|
|
245,319,968 |
|
|
234,725,805 |
|
|
235,928,752 |
|
|
| Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share |
The following table shows securities excluded from the calculation of diluted net income per common share because such securities are anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2025 |
|
2024 |
|
2025 |
|
2024 |
| Options to purchase shares of common stock |
— |
|
|
— |
|
|
— |
|
|
3,750 |
|
| Restricted stock and deferred stock—unvested |
549,099 |
|
|
2,147,167 |
|
|
549,539 |
|
|
2,162,662 |
|
|
|
|
|
|
|
|
|
| Conversion shares related to the convertible senior notes |
14,946,450 |
|
|
— |
|
|
14,946,450 |
|
|
9,225,900 |
|
| Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
15,495,549 |
|
|
2,147,167 |
|
|
15,495,989 |
|
|
11,392,312 |
|
|